Allan Tsung, MD
Secondary Specialty:Surgical Oncology
Education:MD, SUNY Downstate Medical Center, Brooklyn, NY
Residency:University of Pittsburgh School of Medicine, Pittsburgh, PA
Allan Tsung, MD, is an assistant professor in the Department of Surgery, Division of Hepatobiliary, and Pancreatic Surgery at the University of Pittsburgh School of Medicine. Dr. Tsung is a surgical oncologist at the UPMC Liver Cancer Center and UPMC Hillman Cancer Center Pancreatic Cancer Program. His clinical interests center on the evaluation and management of patients with liver, bile duct, and pancreas cancers. He is specialty-trained in liver and pancreatic surgery, with a focus in minimally invasive (laparoscopic and robotic) surgery. Dr. Tsung also co-leads the liver-directed therapy program utilizing hepatic artery chemoembolization and Yttrium 90 internal radiation for primary and metastatic liver cancers, bile duct cancers, and gallbladder carcinoma.
Dr. Tsung's primary research interest is directed toward hepatobiliary clinical trials and the role of inflammation in tumorigenesis of primary and metastatic liver cancers. Dr. Tsung has active research grants from the Howard Hughes Medical Institute and the NIH, and is also the principal investigator on multiple clinical trials for liver cancer.
Dr. Tsung is board-certified in general surgery. He received an undergraduate degree at Cornell University in Ithaca, NY, and received a medical degree at the State University of New York in Brooklyn, NY. Dr. Tsung completed a general surgical residency and a fellowship in hepatobiliary and pancreatic surgery at the University of Pittsburgh School of Medicine.
Dr. Tsung is a member of many professional organizations including, the American College of Surgeons, Society of Surgical Oncology, American Hepato-Pancreato-Biliary Association, Association of Academic Surgery, Society of University Surgeons, Shock Society, and Surgical Infection Society. He has also coauthored more than 50 manuscripts and four book chapters.